FDA Warning Letters
This article was originally published in The Silver Sheet
Executive Summary
The following chart lists medical device-related warning letters released by FDA from Aug. 11 through Sept. 8. If an inspection led to the warning letter, the location of the inspected facility and dates of inspection are noted; otherwise, the location of the warning letter recipient is listed.
You may also be interested in...
Hospira recalls devices on heels of FDA warning letter
Drug-delivery device maker Hospira initiated a nationwide recall Aug. 14 of more than 30 types of devices with defective power cords that may crack and fail, potentially resulting in electrical shock, therapy delays, device failure and fires. The devices include the Acclaim Encore infusion pump, Omniflow and GemStar medication management system components, Q2 and QVue cardiac monitoring systems, and items in the LifeCare and Plum infusion pump lines. The recall came two days after FDA sent a warning letter to Hospira citing quality system regulation violations related to the faulty cords (See "1Warning Letters."
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.